Log in to save to my catalogue

Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with fami...

Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with fami...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3fbe7b4d45af40c48226a8105f5b78fb

Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever

About this item

Full title

Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2024-11, Vol.10 (4), p.e004677

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

IntroductionFamilial Mediterranean fever (FMF) is a genetic disease leading to recurrent episodes of inflammation. Two pathogenic variants are required for classical disease, but the disease can occur in heterozygous patients. Patients are treated continuously with colchicine to prevent amyloid A (AA) amyloidosis, including heterozygous patients wh...

Alternative Titles

Full title

Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3fbe7b4d45af40c48226a8105f5b78fb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3fbe7b4d45af40c48226a8105f5b78fb

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2024-004677

How to access this item